Skip to main content

Showing 1–3 of 3 results for author: Shaw, D E

Searching in archive cs. Search in all archives.
.
  1. arXiv:2201.08357  [pdf

    cs.AR

    The Specialized High-Performance Network on Anton 3

    Authors: Keun Sup Shim, Brian Greskamp, Brian Towles, Bruce Edwards, J. P. Grossman, David E. Shaw

    Abstract: Molecular dynamics (MD) simulation, a computationally intensive method that provides invaluable insights into the behavior of biomolecules, typically requires large-scale parallelization. Implementation of fast parallel MD simulation demands both high bandwidth and low latency for inter-node communication, but in current semiconductor technology, neither of these properties is scaling as quickly a… ▽ More

    Submitted 20 January, 2022; originally announced January 2022.

    Comments: Accepted by the 28th IEEE International Symposium on High-Performance Computer Architecture (HPCA 2022)

  2. arXiv:2008.06431  [pdf, other

    stat.ML cs.LG

    Efficient hyperparameter optimization by way of PAC-Bayes bound minimization

    Authors: John J. Cherian, Andrew G. Taube, Robert T. McGibbon, Panagiotis Angelikopoulos, Guy Blanc, Michael Snarski, Daniel D. Richman, John L. Klepeis, David E. Shaw

    Abstract: Identifying optimal values for a high-dimensional set of hyperparameters is a problem that has received growing attention given its importance to large-scale machine learning applications such as neural architecture search. Recently developed optimization methods can be used to select thousands or even millions of hyperparameters. Such methods often yield overfit models, however, leading to poor p… ▽ More

    Submitted 14 August, 2020; originally announced August 2020.

  3. arXiv:2002.02948  [pdf

    cs.LG stat.ML

    A deep-learning view of chemical space designed to facilitate drug discovery

    Authors: Paul Maragakis, Hunter Nisonoff, Brian Cole, David E. Shaw

    Abstract: Drug discovery projects entail cycles of design, synthesis, and testing that yield a series of chemically related small molecules whose properties, such as binding affinity to a given target protein, are progressively tailored to a particular drug discovery goal. The use of deep learning technologies could augment the typical practice of using human intuition in the design cycle, and thereby exped… ▽ More

    Submitted 7 February, 2020; originally announced February 2020.